By MIHIR ZAVERI and KATIE THOMAS
NYT Health
A Philadelphia jury found that a subsidiary downplayed the risks that the anti-psychotic drug could lead to breast growth in boys.
Published date: October 8, 2019 at 03:00AM
Tuesday, October 8, 2019
New Your Times - Health - Johnson & Johnson Hit With $8 Billion Jury Verdict in Risperdal Suit
By MIHIR ZAVERI and KATIE THOMAS
NYT Health
A Philadelphia jury found that a subsidiary downplayed the risks that the anti-psychotic drug could lead to breast growth in boys.
Published date: October 8, 2019 at 03:00AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment